In neurodegenerative diseases, disruptions in MAM structure or tethering proteins such as MFN2 impair autophagosome formation and mitochondrial clearance, resulting in the accumulation of damaged organelles and aggregated proteins, as observed in Alzheimer’s, Parkinson’s, and Huntington’s disease models [22]. Here, MFN2 is linked to Parkinson disease.